{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:59:57Z","timestamp":1759366797500,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtha.2024.06.014","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T18:38:36Z","timestamp":1719686316000},"page":"2810-2822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel factor V compound heterozygous mutation associated with thrombosis (Y1961C; FV-Kanazawa, together with 1982_1983del)"],"prefix":"10.1016","volume":"22","author":[{"given":"Naruto","family":"Shimonishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoji","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.06.014_bib1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlb\u00e4ck","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.06.014_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2024.06.014_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0038-1657564","article-title":"Coagulation factor V: an old star shines again","volume":"78","author":"Rosing","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.014_bib4","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1016\/S0021-9258(20)65178-X","article-title":"Thrombin-catalyzed activation of human coagulation factor V","volume":"257","author":"Suzuki","year":"1982","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib5","doi-asserted-by":"crossref","first-page":"13970","DOI":"10.1016\/S0021-9258(17)44011-7","article-title":"The factor Xa-catalyzed activation of factor V","volume":"258","author":"Foster","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0005-2744(79)90103-7","article-title":"The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V","volume":"571","author":"Walker","year":"1979","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtha.2024.06.014_bib7","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0021-9258(18)33076-X","article-title":"Inactivation of human coagulation factor V by activated protein C","volume":"258","author":"Suzuki","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib8","doi-asserted-by":"crossref","first-page":"21158","DOI":"10.1074\/jbc.270.36.21158","article-title":"Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C","volume":"270","author":"Nicolaes","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1110\/ps.0210002","article-title":"Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C","volume":"11","author":"Gale","year":"2002","journal-title":"Protein Sci"},{"key":"10.1016\/j.jtha.2024.06.014_bib10","doi-asserted-by":"crossref","first-page":"16355","DOI":"10.1074\/jbc.M708985200","article-title":"Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V","volume":"283","author":"Gale","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib11","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1182\/blood.V95.5.1714.005k40_1714_1720","article-title":"Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase","volume":"95","author":"O\u2019Brien","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib12","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1074\/jbc.273.26.16140","article-title":"The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V","volume":"273","author":"Thorelli","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib13","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1182\/blood.V87.11.4708.bloodjournal87114708","article-title":"Comparison of activated protein C\/protein S-mediated inactivation of human factor VIII and factor V","volume":"87","author":"Lu","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib14","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.06.014_bib15","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016341","article-title":"Regulation of factor V and factor V-short by TFPI\u03b1: relationship between B-domain proteolysis and binding","volume":"296","author":"Petrillo","year":"2021","journal-title":"J\u00a0Biol Chem"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2024.06.014_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ijlh.12508","article-title":"Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders","volume":"38","author":"Dahlb\u00e4ck","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.06.014_bib17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/jth.13665","article-title":"Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitor\u03b1, and protein S","volume":"15","author":"Dahlb\u00e4ck","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.014_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/jth.12126","article-title":"A\u00a0new regulatory function of activated factor V: inhibition of the activation by tissue factor\/factor VII(a) of factor X","volume":"11","author":"Al Dieri","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.014_bib19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V91.4.1140","article-title":"Factor V Cambridge: a new mutation (Arg306\u2013>Thr) associated with resistance to activated protein C","volume":"91","author":"Williamson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V91.4.1135","article-title":"A\u00a0novel mutation of Arg306 of factor V gene in Hong Kong Chinese","volume":"91","author":"Chan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib21","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1182\/blood-2003-06-2092","article-title":"Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis","volume":"103","author":"Steen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.thromres.2010.02.009","article-title":"A\u00a0novel mutation (g2172\u2013>c) in the factor V gene in a Chinese family with hereditary activated protein C resistance","volume":"125","author":"Cai","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.06.014_bib23","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/jth.13339","article-title":"Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn) associated with activated protein C resistance","volume":"14","author":"Pezeshkpoor","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.014_bib24","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2013-10-530089","article-title":"Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden","volume":"123","author":"Nogami","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib25","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/jth.14594","article-title":"The roles of factor Va and protein S in formation of the activated protein C\/protein S\/factor Va inactivation complex","volume":"17","author":"Gierula","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.014_bib26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/jth.15274","article-title":"Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besan\u00e7on)","volume":"19","author":"Castoldi","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.014_bib27","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1182\/bloodadvances.2022008918","article-title":"Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations","volume":"7","author":"Shimonishi","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.014_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1021\/bi00507a028","article-title":"Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside","volume":"20","author":"Mimms","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2024.06.014_bib29","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1074\/jbc.M804955200","article-title":"The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex","volume":"284","author":"Soeda","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2008.11.017","article-title":"A\u00a0new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study","volume":"124","author":"Toulon","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.06.014_bib31","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1055\/s-0041-1723996","article-title":"Acidic region residues 1680-1684 in the A3 domain of factor VIII contain a thrombin-interactive site responsible for proteolytic cleavage at Arg1689","volume":"121","author":"Nakajima","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.014_bib32","doi-asserted-by":"crossref","first-page":"18735","DOI":"10.1016\/S0021-9258(17)32228-7","article-title":"Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa","volume":"269","author":"Shen","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/bi00168a013","article-title":"Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor","volume":"33","author":"Kalafatis","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2024.06.014_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1160\/TH03-04-0222","article-title":"The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis","volume":"91","author":"Saleh","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.014_bib35","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1074\/jbc.M213044200","article-title":"Mechanisms of factor Xa-catalyzed cleavage of the factor VIIIa A1 subunit resulting in cofactor inactivation","volume":"278","author":"Nogami","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.06.014_bib36","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2141.1997.3993213.x","article-title":"Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V","volume":"99","author":"Castaman","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.06.014_bib38","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood-2005-04-1461","article-title":"An underestimated combination of opposites resulting in enhanced thrombotic tendency","volume":"106","author":"Simioni","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib39","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPI\u03b1","volume":"123","author":"Vincent","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.06.014_bib40","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with\u00a0congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.014_bib41","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1074\/jbc.M116.769570","article-title":"Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation","volume":"292","author":"Santamaria","year":"2017","journal-title":"J\u00a0Biol Chem"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:46:13Z","timestamp":1759351573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1538783624003738"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.014","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel factor V compound heterozygous mutation associated with thrombosis (Y1961C; FV-Kanazawa, together with 1982_1983del)","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}